LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 derivative and preparation thereof absorbable via...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 exendin-4 peptide analogs and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 formulations with protracted time action

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-1 fusion proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GLP-2 formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon analogs with ASP.sup.9 replacements or deletions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon analogs with serine replacements

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon analogs with serine replacements

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon homologs and therapeutic use thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon-like insulinotropic peptide analogs, compositions, and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon-like insulinotropic peptides compositions and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon-like insulinotropic peptides, compositions and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon-like insulinotropic peptides, compositions and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon-like insulinotropic peptides, compositions and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glucagon-like insulinotropic peptides, compositions and methods